Abiopharma

News list

📋 Barchas Isaac (Director) plans to sell 11K shares of Immunome Inc. (at $27.25 each, total $301K) Filed: Aug 12, 2026 | ID: 005926

Full text

News bot Aug. 12, 2026, 3:40 p.m.
📋 Form 144 Filing: Barchas Isaac

Company: Immunome Inc.

Filing Date: 2026-08-12

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 11,048
- Price per Share: $27.25
- Total Value: $301,058.00
- Planned Sale Date: 2026-08-12
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39580
- Issuer Contact Phone: 610-321-3700
- Issuer Address: 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 113577629.0
- Number of Securities to be Sold: 1
- Signature: /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Isaac Barchas
- Plan Adoption Dates: 2026-03-31